30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

MyoKardia Inc (MYOK)

Track

Stock chart
Ticker: MYOK Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
GIANAKAKOS ANASTASIOS
President and CEO
2 sales — total 469,909 USD
Planned sale 2 Jul 2020
Value US$3,710,093.07 | Price 462.52 | Shares 21,065
Planned sale 2 Jul 2020
Value US$4,631,787.93 | Price 17.54 | Shares 91,152
Sale 30 Jun 2020
Value US$1,441,280.69 | Price 456.51 | Shares 35,375
Sale 30 Jun 2020
Value US$689,180.22 | Price 337.15 | Shares 48,462
Sale 29 Jun 2020
Value US$36,611.06 | Price 98.68 | Shares 371
Planned sale 2 Jun 2020
Value US$33,381.63 | Price 104.64 | Shares 319
Planned sale 2 Jun 2020
Value US$195,609.47 | Price 103.77 | Shares 1,885
Planned sale 2 Jun 2020
Value US$143,481.44 | Price 102.78 | Shares 1,396
Planned sale 2 Jun 2020
Value US$81,378.00 | Price 101.72 | Shares 800
Planned sale 2 Jun 2020
Value US$60,357.00 | Price 100.60 | Shares 600
Planned sale 18 May 2020
Value US$1,250,000.00 | Price 125.00 | Shares 10,000
Planned sale 11 May 2020
Value US$61,998.00 | Price 103.33 | Shares 600
Planned sale 11 May 2020
Value US$360,920.96 | Price 102.56 | Shares 3,519
Planned sale 11 May 2020
Value US$1,893,485.66 | Price 101.90 | Shares 18,581
Planned sale 11 May 2020
Value US$170,859.52 | Price 100.51 | Shares 1,700
Planned sale 11 May 2020
Value US$59,212.98 | Price 98.69 | Shares 600
Planned sale 4 May 2020
Value US$18,346.36 | Price 60.15 | Shares 305
Planned sale 4 May 2020
Value US$171,915.79 | Price 59.10 | Shares 2,909
Planned sale 4 May 2020
Value US$23,218.00 | Price 58.05 | Shares 400
Planned sale 4 May 2020
Value US$78,907.34 | Price 56.93 | Shares 1,386
Planned sale 16 Apr 2020
Value US$55,000.00 | Price 55.00 | Shares 1,000
Planned sale 8 Apr 2020
Value US$75,000.00 | Price 50.00 | Shares 1,500
Sale 6 Apr 2020
Value US$61,321.95 | Price 46.99 | Shares 1,305
Planned sale 2 Apr 2020
Value US$27,736.02 | Price 46.23 | Shares 600
Planned sale 2 Apr 2020
Value US$13,605.00 | Price 45.35 | Shares 300
Planned sale 2 Apr 2020
Value US$44,469.00 | Price 44.47 | Shares 1,000
Planned sale 2 Apr 2020
Value US$26,107.02 | Price 43.51 | Shares 600
Planned sale 2 Mar 2020
Value US$1,451.34 | Price 65.97 | Shares 22
Planned sale 2 Mar 2020
Value US$117,345.60 | Price 65.19 | Shares 1,800
Planned sale 2 Mar 2020
Value US$133,202.84 | Price 64.35 | Shares 2,070
Planned sale 2 Mar 2020
Value US$70,246.42 | Price 63.40 | Shares 1,108
Planned sale 3 Feb 2020
Value US$69,744.00 | Price 69.74 | Shares 1,000
Planned sale 3 Feb 2020
Value US$277,076.80 | Price 69.27 | Shares 4,000
Sale 1 Feb 2020
Value US$197,247.96 | Price 68.04 | Shares 2,899
Planned sale 14 Jan 2020
Value US$376,964.50 | Price 75.39 | Shares 5,000
Sale 6 Jan 2020
Value US$115,203.20 | Price 68.45 | Shares 1,683
Sale 6 Jan 2020
Value US$126,566.08 | Price 68.45 | Shares 1,849
Sale 6 Jan 2020
Value US$181,395.42 | Price 68.45 | Shares 2,650
Sale 6 Jan 2020
Value US$168,800.41 | Price 68.45 | Shares 2,466
Sale 6 Jan 2020
Value US$868,439.11 | Price 68.45 | Shares 12,687
Planned sale 3 Jan 2020
Value US$150,616.52 | Price 72.27 | Shares 2,084
Planned sale 3 Jan 2020
Value US$187,286.50 | Price 71.59 | Shares 2,616
Planned sale 3 Jan 2020
Value US$21,105.00 | Price 70.35 | Shares 300
Planned sale 20 Dec 2019
Value US$1,325,421.42 | Price 70.07 | Shares 18,916
Planned sale 2 Dec 2019
Value US$283,342.47 | Price 65.14 | Shares 4,350
Planned sale 2 Dec 2019
Value US$41,755.48 | Price 64.24 | Shares 650
Planned sale 29 Nov 2019
Value US$53,056.00 | Price 66.32 | Shares 800
Planned sale 29 Nov 2019
Value US$480,654.72 | Price 65.52 | Shares 7,336
Planned sale 27 Nov 2019
Value US$852,976.53 | Price 65.13 | Shares 13,096
Planned sale 4 Nov 2019
Value US$295,364.50 | Price 59.07 | Shares 5,000
Planned sale 3 Oct 2019
Value US$55,000.00 | Price 55.00 | Shares 1,000
Planned sale 2 Oct 2019
Value US$40,247.75 | Price 53.10 | Shares 758
Planned sale 2 Oct 2019
Value US$132,933.13 | Price 52.29 | Shares 2,542
Planned sale 2 Oct 2019
Value US$35,930.02 | Price 51.33 | Shares 700
Planned sale 23 Sep 2019
Value US$254,191.33 | Price 61.09 | Shares 4,161
Planned sale 23 Sep 2019
Value US$47,960.00 | Price 59.95 | Shares 800
Planned sale 23 Sep 2019
Value US$245,389.15 | Price 58.97 | Shares 4,161
Planned sale 23 Sep 2019
Value US$229,183.68 | Price 58.33 | Shares 3,929
Planned sale 20 Sep 2019
Value US$1,183,776.94 | Price 60.09 | Shares 19,700
Planned sale 19 Sep 2019
Value US$310,253.71 | Price 57.08 | Shares 5,435
Planned sale 11 Sep 2019
Value US$55,000.00 | Price 55.00 | Shares 1,000
Planned sale 3 Sep 2019
Value US$59,499.99 | Price 54.09 | Shares 1,100
Planned sale 3 Sep 2019
Value US$52,750.00 | Price 52.75 | Shares 1,000
Planned sale 3 Sep 2019
Value US$96,334.75 | Price 50.70 | Shares 1,900
Planned sale 9 Aug 2019
Value US$260,218.70 | Price 57.00 | Shares 4,565
Planned sale 8 Aug 2019
Value US$55,090.00 | Price 55.09 | Shares 1,000
Planned sale 2 Aug 2019
Value US$10,763.50 | Price 53.82 | Shares 200
Planned sale 2 Aug 2019
Value US$202,171.40 | Price 53.20 | Shares 3,800
Planned sale 22 Jul 2019
Value US$55,000.00 | Price 55.00 | Shares 1,000
Planned sale 5 Jul 2019
Value US$122,751.86 | Price 50.10 | Shares 2,450
Planned sale 5 Jul 2019
Value US$76,151.19 | Price 49.13 | Shares 1,550
Sale 5 Apr 2019
Value US$70,569.20 | Price 53.30 | Shares 1,324
Sale 13 Feb 2019
Value US$157,000,736.34 | Price 37.66 | Shares 4,168,899
Sale 7 Jan 2019
Value US$122,197.44 | Price 44.11 | Shares 2,770
Buy 4 Jan 2019
Value US$63,795.52 | Price 39.87 | Shares 1,600
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-07-07 2020-07-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
21,065 +26.6%
462.52
US$3,710,093 		21,065 +26.6% 462.52 US$3,710,093
2020-07-07 2020-07-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
91,152 -12.2%
17.54
US$4,631,788 		91,152 -12.2% 17.54 US$4,631,788
2020-07-01 2020-06-30 S Sale
1.5
CRANSTON MARY B
Non-Executive Director
35,375 -41.1%
456.51
US$1,441,281 		35,375 -41.1% 456.51 US$1,441,281
2020-07-01 2020-06-30 S Sale
1.5
CRANSTON MARY B
Non-Executive Director
300 -1.4%
97.25
US$29,176 		300 -1.4% 97.25 US$29,176
2020-07-01 2020-06-29 S Sale
1.5
CRANSTON MARY B
Non-Executive Director
371 -100.0%
98.68
US$36,611 		371 -100.0% 98.68 US$36,611
2020-06-04 2020-06-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
319 -1.3%
104.64
US$33,382 		319 -1.3% 104.64 US$33,382
2020-06-04 2020-06-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,885 -7.2%
103.77
US$195,609 		1,885 -7.2% 103.77 US$195,609
2020-06-04 2020-06-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,396 -5.0%
102.78
US$143,481 		1,396 -5.0% 102.78 US$143,481
2020-06-04 2020-06-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
800 -2.8%
101.72
US$81,378 		800 -2.8% 101.72 US$81,378
2020-06-04 2020-06-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -2.1%
100.60
US$60,357 		600 -2.1% 100.60 US$60,357
2020-05-20 2020-05-18 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
10,000 -25.6%
125.00
US$1,250,000 		10,000 -25.6% 125.00 US$1,250,000
2020-05-13 2020-05-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -1.5%
103.33
US$61,998 		600 -1.5% 103.33 US$61,998
2020-05-13 2020-05-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
3,519 -8.1%
102.56
US$360,921 		3,519 -8.1% 102.56 US$360,921
2020-05-13 2020-05-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
18,581 -30.1%
101.90
US$1,893,486 		18,581 -30.1% 101.90 US$1,893,486
2020-05-13 2020-05-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,700 -2.7%
100.51
US$170,860 		1,700 -2.7% 100.51 US$170,860
2020-05-13 2020-05-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.9%
98.69
US$59,213 		600 -0.9% 98.69 US$59,213
2020-05-06 2020-05-04 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
305 -0.4%
60.15
US$18,346 		305 -0.4% 60.15 US$18,346
2020-05-06 2020-05-04 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,909 -3.8%
59.10
US$171,916 		2,909 -3.8% 59.10 US$171,916
2020-05-06 2020-05-04 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
400 -0.5%
58.05
US$23,218 		400 -0.5% 58.05 US$23,218
2020-05-06 2020-05-04 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,386 -1.8%
56.93
US$78,907 		1,386 -1.8% 56.93 US$78,907
2020-04-20 2020-04-16 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.3%
55.00
US$55,000 		1,000 -1.3% 55.00 US$55,000
2020-04-10 2020-04-08 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,500 -1.9%
50.00
US$75,000 		1,500 -1.9% 50.00 US$75,000
2020-04-07 2020-04-06 S Sale
0.5
Harris Taylor C.

Chief Financial Officer

Officer
1,305 -14.9%
46.99
US$61,322 		1,305 -14.9% 46.99 US$61,322
2020-04-06 2020-04-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.8%
46.23
US$27,736 		600 -0.8% 46.23 US$27,736
2020-04-06 2020-04-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
300 -0.4%
45.35
US$13,605 		300 -0.4% 45.35 US$13,605
2020-04-06 2020-04-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.2%
44.47
US$44,469 		1,000 -1.2% 44.47 US$44,469
2020-04-06 2020-04-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
600 -0.7%
43.51
US$26,107 		600 -0.7% 43.51 US$26,107
2020-03-04 2020-03-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
22 -0.0%
65.97
US$1,451 		22 -0.0% 65.97 US$1,451
2020-03-04 2020-03-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,800 -2.2%
65.19
US$117,346 		1,800 -2.2% 65.19 US$117,346
2020-03-04 2020-03-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,070 -2.4%
64.35
US$133,203 		2,070 -2.4% 64.35 US$133,203
2020-03-04 2020-03-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,108 -1.3%
63.40
US$70,246 		1,108 -1.3% 63.40 US$70,246
2020-02-05 2020-02-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.1%
69.74
US$69,744 		1,000 -1.1% 69.74 US$69,744
2020-02-05 2020-02-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
4,000 -4.4%
69.27
US$277,077 		4,000 -4.4% 69.27 US$277,077
2020-02-03 2020-02-01 S Sale
0.6
Fairey William

See Remarks
2,899 -35.7%
68.04
US$197,248 		2,899 -35.7% 68.04 US$197,248
2020-01-14 2020-01-14 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
5,000 -5.2%
75.39
US$376,964 		5,000 -5.2% 75.39 US$376,964
2020-01-07 2020-01-06 S Sale
0.5
Harris Taylor C.

Chief Financial Officer
1,683 -25.2%
68.45
US$115,203 		1,683 -25.2% 68.45 US$115,203
2020-01-07 2020-01-06 S Sale
LADD CYNTHIA J

General Counsel
1,849 -39.3%
68.45
US$126,566 		1,849 -39.3% 68.45 US$126,566
2020-01-07 2020-01-06 S Sale
McDowell Robert Scott

Chief Scientific Officer
2,650 -33.0%
68.45
US$181,395 		2,650 -33.0% 68.45 US$181,395
2020-01-07 2020-01-06 S Sale
Bauer Jake

Chief Business Officer
2,466 -4.1%
68.45
US$168,800 		2,466 -4.1% 68.45 US$168,800
2020-01-07 2020-01-06 S Sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
12,687 -11.6%
68.45
US$868,439 		12,687 -11.6% 68.45 US$868,439
2020-01-03 2020-01-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,084 -1.9%
72.27
US$150,617 		2,084 -1.9% 72.27 US$150,617
2020-01-03 2020-01-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,616 -2.3%
71.59
US$187,287 		2,616 -2.3% 71.59 US$187,287
2020-01-03 2020-01-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
300 -0.3%
70.35
US$21,105 		300 -0.3% 70.35 US$21,105
2019-12-23 2019-12-20 PlS Planned sale Bauer Jake

Chief Business Officer

Officer
18,916 -30.3%
70.07
US$1,325,421 		18,916 -30.3% 70.07 US$1,325,421
2019-12-04 2019-12-02 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
4,350 -4.8%
65.14
US$283,342 		4,350 -4.8% 65.14 US$283,342
2019-12-04 2019-12-02 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
650 -0.7%
64.24
US$41,755 		650 -0.7% 64.24 US$41,755
2019-12-02 2019-11-29 PlS Planned sale Bauer Jake

Chief Business Officer

Officer
800 -1.7%
66.32
US$53,056 		800 -1.7% 66.32 US$53,056
2019-12-02 2019-11-29 PlS Planned sale Bauer Jake

Chief Business Officer

Officer
7,336 -13.8%
65.52
US$480,655 		7,336 -13.8% 65.52 US$480,655
2019-12-02 2019-11-27 PlS Planned sale Bauer Jake

Chief Business Officer

Officer
13,096 -19.8%
65.13
US$852,977 		13,096 -19.8% 65.13 US$852,977
2019-11-06 2019-11-04 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
5,000 -5.2%
59.07
US$295,364 		5,000 -5.2% 59.07 US$295,364
2019-10-04 2019-10-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
55.00
US$55,000 		1,000 -1.0% 55.00 US$55,000
2019-10-04 2019-10-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
758 -0.8%
53.10
US$40,248 		758 -0.8% 53.10 US$40,248
2019-10-04 2019-10-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,542 -2.5%
52.29
US$132,933 		2,542 -2.5% 52.29 US$132,933
2019-10-04 2019-10-02 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
700 -0.7%
51.33
US$35,930 		700 -0.7% 51.33 US$35,930
2019-09-24 2019-09-23 PlS Planned sale
Lee June

EVP, Chief Development Officer
4,161 -50.0%
61.09
US$254,191 		4,161 -50.0% 61.09 US$254,191
2019-09-24 2019-09-23 PlS Planned sale
Lee June

EVP, Chief Development Officer
800 -8.8%
59.95
US$47,960 		800 -8.8% 59.95 US$47,960
2019-09-24 2019-09-23 PlS Planned sale
Lee June

EVP, Chief Development Officer
4,161 -31.3%
58.97
US$245,389 		4,161 -31.3% 58.97 US$245,389
2019-09-24 2019-09-23 PlS Planned sale
Lee June

EVP, Chief Development Officer
3,929 -22.8%
58.33
US$229,184 		3,929 -22.8% 58.33 US$229,184
2019-09-24 2019-09-20 PlS Planned sale
Bauer Jake

Chief Business Officer
19,700 -23.0%
60.09
US$1,183,777 		19,700 -23.0% 60.09 US$1,183,777
2019-09-20 2019-09-19 PlS Planned sale
Lee June

EVP, Chief Development Officer
5,435 -54.3%
57.08
US$310,254 		5,435 -54.3% 57.08 US$310,254
2019-09-12 2019-09-11 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
55.00
US$55,000 		1,000 -1.0% 55.00 US$55,000
2019-09-05 2019-09-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,100 -1.1%
54.09
US$59,500 		1,100 -1.1% 54.09 US$59,500
2019-09-05 2019-09-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -1.0%
52.75
US$52,750 		1,000 -1.0% 52.75 US$52,750
2019-09-05 2019-09-03 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,900 -1.8%
50.70
US$96,335 		1,900 -1.8% 50.70 US$96,335
2019-08-12 2019-08-09 PlS Planned sale Lee June

EVP, Chief Development Officer

Officer
4,565 -49.9%
57.00
US$260,219 		4,565 -49.9% 57.00 US$260,219
2019-08-09 2019-08-08 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -0.9%
55.09
US$55,090 		1,000 -0.9% 55.09 US$55,090
2019-08-05 2019-08-02 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
200 -0.2%
53.82
US$10,764 		200 -0.2% 53.82 US$10,764
2019-08-05 2019-08-02 PlS Planned sale GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
3,800 -3.4%
53.20
US$202,171 		3,800 -3.4% 53.20 US$202,171
2019-07-23 2019-07-22 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,000 -0.9%
55.00
US$55,000 		1,000 -0.9% 55.00 US$55,000
2019-07-08 2019-07-05 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,450 -2.1%
50.10
US$122,752 		2,450 -2.1% 50.10 US$122,752
2019-07-08 2019-07-05 PlS Planned sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,550 -1.3%
49.13
US$76,151 		1,550 -1.3% 49.13 US$76,151
2019-04-09 2019-04-05 S Sale
0.5
Harris Taylor C.

Chief Financial Officer
1,324 -35.3%
53.30
US$70,569 		1,324 -35.3% 53.30 US$70,569
2019-02-15 2019-02-13 S Sale
2.4
Sanofi
Large shareholder
4,168,899 -100.0%
37.66
US$157,000,736 		4,168,899 -100.0% 37.66 US$157,000,736
2019-01-11 2019-01-07 S Sale
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
2,770 -3.5%
44.11
US$122,197 		2,770 -3.5% 44.11 US$122,197
2019-01-08 2019-01-04 B Purchase
GIANAKAKOS ANASTASIOS

President and CEO

Executive Director
1,600 +1.8%
39.87
US$63,796 		1,600 +1.8% 39.87 US$63,796
Explore more

More insider trading research around MyoKardia Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America